Strive Health raises $166 million in Series C funding
Click Here to Manage Email Alerts
Key takeaways:
- Strive Health raised $166 million in Series C funding from investor partners.
- The new funds will be used to expand new markets and refine the value-based care model.
Strive Health has raised $166 million in Series C funding from its investor partners, which include five new investors, according to a press release.
“Since our founding, we’ve strongly believed that we must meaningfully change the standard of kidney care so people with kidney disease can have better access to care regardless of their socioeconomic background,” Chris Riopelle, CEO and co-founder of Strive Health, said in the release. “With the help of our investor partners, this capital raise will propel us further along in our journey to transform kidney care.”
Strive Health’s value-based care approach to kidney disease has reduced the total cost of kidney care by 20% and resulted in a 42% reduction in hospitalizations, according to the release. Strive serves about 80,000 patients with chronic kidney disease and end-stage kidney disease across 30 states.
The company plans to use the new funds to expand into new markets and refine its value-based care model, as well as invest in its 550 employees.
Read more about
Click Here to Manage Email Alerts